Estimating Cardiovascular Benefits of Tirzepatide in Sleep Apnea and Obesity: Insight from the SURMOUNT-OSA Trials
Sign Up to like & getrecommendations! Published in 2024 at "Current Obesity Reports"
DOI: 10.1007/s13679-024-00592-x
Abstract: This commentary aims to offer a perspective on the effect of tirzepatide on hypoxic burden and provide indirect evidence of cardiovascular risk reduction after tirzepatide for the treatment of obstructive sleep apnea and obesity. It… read more here.
Keywords: obesity; sleep apnea; apnea obesity; hypoxic burden ... See more keywords